Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0502
0.00 (0.00%)
Apr 8, 2026, 12:23 PM EST
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $286.92 thousand as of April 8, 2026. Its market cap has decreased by -79.45% in one year.
Market Cap
286.92K
Enterprise Value
1.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 286.92K, a decrease of -99.83%. That is a compound annual growth rate of -42.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 286.92K | -45.72% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EV Biologics | 536.83K |
| Windtree Therapeutics | 463.38K |
| Regenerative Medical Technology Group | 394.17K |
| Actavia Life Sciences | 385.91K |
| Abpro Holdings | 370.64K |
| Innovation Pharmaceuticals | 370.14K |
| Helix BioMedix | 224.71K |
| Regen BioPharma | 210.86K |